Stem cell therapy updates medical practices by creating new ways to treat orthopedic problems and health degenerations. Patients confront the largest problem when considering treatment-associated ...

On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...

Lisocabtagene maraleucel shows superior 3-year outcomes over standard care in second-line large B-cell lymphoma.

There's a huge advantage to using allogeneic CAR T cells vs autologous CAR T cells. And large B-cell lymphoma has proven to be sensitive to autologous CAR T cells, so we want to extend that into ...

Plug Power Inc. PLUG and Bloom Energy Corporation BE are both familiar names operating in the fuel cell technology market. As rivals, both companies are engaged in manufacturing innovative fuel ...

The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered, in a new study in mice and humans from researchers at UCL, the ...

Impact of standard vs reduced dosing of sotorasib on efficacy and toxicity in KRAS G12C–mutated advanced non-small cell lung cancer: A systematic review and meta-analysis.

A phase 1/2 clinical trial of quaratusugene ozeplasmid gene therapy and atezolizumab maintenance therapy in patients with extensive stage small cell lung cancer (ES-SCLC). This is an ASCO Meeting ...